FASN was dramatically increased in CRPC mouse tissues (Figure S4A) and prostate cancer patient tissues (Figure S4B), as shown in the expression signature of prostate cancer patients (Figure S4C) [28]. This evidence concerns the gene FASN and prostate carcinoma.